We are live on ! Find out more
CCC

Crescent Capital Consulting Portfolio holdings

AUM $607M
1-Year Est. Return 22.88%
This Fund
S&P 500
This Quarter Est. Return
+6.59%
1 Year Est. Return
+22.88%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$534M
AUM Growth
+$78.2M
Cap. Flow
+$75.8M
Cap. Flow %
14.19%
Top 10 Hldgs %
38.48%
Holding
571
New
47
Increased
80
Reduced
111
Closed
70

Top Buys

Rank Stock Value
1
IWF icon
iShares Russell 1000 Growth ETF
IWF
+$27.1M
2
BSJN
Invesco BulletShares 2023 High Yield Corporate Bond ETF
BSJN
+$15.6M
3
BSCN
Invesco BulletShares 2023 Corporate Bond ETF
BSCN
+$15.5M
4
ACWX icon
iShares MSCI ACWI ex US ETF
ACWX
+$11.5M
5
VONV icon
Vanguard Russell 1000 Value ETF
VONV
+$10.8M

Top Sells

Rank Stock Value
1
BSJL
Invesco BulletShares 2021 High Yield Corporate Bond ETF
BSJL
+$10.8M
2
IGIB icon
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
+$9.63M
3
EFAV icon
iShares MSCI EAFE Min Vol Factor ETF
EFAV
+$7.99M
4
BSCP
Invesco BulletShares 2025 Corporate Bond ETF
BSCP
+$7.37M
5
IWB icon
iShares Russell 1000 ETF
IWB
+$2.47M

Sector Composition

Rank Sector Weight
1 Technology 5.1%
2 Healthcare 4.53%
3 Materials 3.45%
4 Consumer Staples 3.39%
5 Financials 2.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ROP icon
101
Roper Technologies
ROP
$38.8B
$588K 0.11%
1,250
– –
AXP icon
102
American Express
AXP
$233B
$575K 0.11%
3,475
– –
VAW icon
103
Vanguard Materials ETF
VAW
$2.99B
$553K 0.1%
3,060
+55
+2% +$10.2K
HPQ icon
104
HP
HPQ
$24.8B
$548K 0.1%
18,200
– –
TXN icon
105
Texas Instruments
TXN
$246B
$545K 0.1%
2,836
-8
-0.3% -$1.5K
MRNA icon
106
PUT
Moderna
MRNA
$21.9B
$540K 0.1%
+3
New +$536
MPLX icon
107
MPLX
MPLX
$59.8B
$496K 0.09%
16,751
– –
RRBI icon
108
Red River Bancshares
RRBI
$670M
$477K 0.09%
9,437
– –
FFH
109
DELISTED
FAIRFAX FINL HLDGS LTD SUB VTG
FFH
$463K 0.09%
1,056
– –
CL icon
110
Colgate-Palmolive
CL
$71.9B
$450K 0.08%
5,524
– –
IWB icon
111
iShares Russell 1000 ETF
IWB
$49B
$446K 0.08%
1,843
-10,471
-85% -$2.47M
META icon
112
Meta Platforms (Facebook)
META
$1.5T
$439K 0.08%
1,260
-455
-27% -$146K
BDX icon
113
Becton Dickinson
BDX
$46.9B
$425K 0.08%
1,794
– –
PEP icon
114
PepsiCo
PEP
$191B
$418K 0.08%
2,823
-31
-1% -$4.52K
MDLZ icon
115
Mondelez International
MDLZ
$78.8B
$405K 0.08%
6,501
– –
MRNA icon
116
Moderna
MRNA
$21.9B
$402K 0.08%
1,712
+200
+13% +$35.7K
RF icon
117
Regions Financial
RF
$26.9B
$390K 0.07%
19,342
+342
+2% +$7.4K
RTX icon
118
RTX Corp
RTX
$292B
$384K 0.07%
4,510
– –
AGG icon
119
iShares Core US Aggregate Bond ETF
AGG
$137B
$383K 0.07%
3,317
+68
+2% +$7.79K
RDS.A
120
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$383K 0.07%
9,532
-1,550
-14% -$61.6K
V icon
121
Visa
V
$683B
$382K 0.07%
1,633
-42
-3% -$9.6K
WELL icon
122
Welltower
WELL
$168B
$380K 0.07%
4,586
– –
TMO icon
123
Thermo Fisher Scientific
TMO
$213B
$378K 0.07%
750
-31
-4% -$14.6K
ENB icon
124
Enbridge
ENB
$118B
$377K 0.07%
9,422
-2,196
-19% -$85K
SAFM
125
DELISTED
Sanderson Farms Inc
SAFM
$376K 0.07%
2,000
– –
3 4
5
6 7

Similar funds

BCA
Biltmore Capital Advisors Princeton, New Jersey $599M AUM 20.23% 1-Year Est. Return
AC
Alley Company Lake Forest, Illinois $631M AUM 24.9% 1-Year Est. Return
QCM
Quest Capital Management Dallas, Texas $582M AUM 31.4% 1-Year Est. Return
VIMU
Veritas Investment Management (UK) London, United Kingdom $648M AUM 36.52% 1-Year Est. Return
HAM
Hillcrest Asset Management Plano, Texas $656M AUM 31.12% 1-Year Est. Return
SIM
SCGF III Management Menlo Park, California $673M AUM
NG
Newmark Group New York $525M AUM
AWM
Altavista Wealth Management Asheville, North Carolina $496M AUM 20.88% 1-Year Est. Return

Crescent Capital Consulting's Q2 2021 Portfolio in Review

As of Q2 2021, Crescent Capital Consulting held 571 positions worth $534M, up 17% from $456M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Crescent Capital Consulting deployed $75.8M of net new capital in Q2 2021, opening 47 new positions and adding to 80 existing holdings. Its largest new stake was Invesco BulletShares 2023 High Yield Corporate Bond ETF: 613,192 shares worth $15.6M.

By sector, the portfolio is most concentrated in Technology at 5.1% of assets, down from 5.5% a quarter earlier, followed by Healthcare and Materials.

On the sell side, the largest reduction was Invesco BulletShares 2021 High Yield Corporate Bond ETF, an estimated $10.8M trimmed.

  • Crescent Capital Consulting's largest Q2 2021 buy was Invesco BulletShares 2023 High Yield Corporate Bond ETF: 613,192 shares worth $15.6M.
  • Crescent Capital Consulting added most to iShares Russell 1000 Growth ETF in Q2 2021, an estimated $27.1M increase.
  • Crescent Capital Consulting's biggest Q2 2021 reduction was Invesco BulletShares 2021 High Yield Corporate Bond ETF, cutting an estimated $10.8M.
  • Crescent Capital Consulting fully exited State Street SPDR Bloomberg Short Term High Yield Bond ETF in Q2 2021, selling an estimated $273K.
  • Crescent Capital Consulting's ten largest holdings make up 38% of its $534M portfolio in Q2 2021.
  • Crescent Capital Consulting opened 47 new positions and closed 70 in Q2 2021.
  • Crescent Capital Consulting's portfolio value rose 17% quarter-over-quarter to $534M.

Based on Crescent Capital Consulting's 13F filing for Q2 2021, filed 15 Jul 2021.